JP2005502322A
(ja)
|
2001-04-19 |
2005-01-27 |
ザ スクリップス リサーチ インスティテュート |
非天然アミノ酸のインビボ組込み
|
ATE445709T1
(de)
*
|
2002-10-16 |
2009-10-15 |
Scripps Research Inst |
Glycoproteinsynthese
|
CN101223272B
(zh)
|
2003-04-17 |
2013-04-03 |
斯克利普斯研究院 |
扩展真核生物遗传密码
|
EP1636340A4
(de)
|
2003-06-18 |
2009-02-11 |
Scripps Research Inst |
Ergänzungen zum genetischen code von unnatürlichen reaktiven aminosäuren
|
AU2004267359B2
(en)
*
|
2003-07-07 |
2010-09-09 |
The Scripps Research Institute |
Compositions of orthogonal lysyl-tRNA and aminoacyl-tRNA synthetase pairs and uses thereof
|
DK1687401T3
(da)
|
2003-10-14 |
2013-02-04 |
Scripps Research Inst |
Sted-spicifik inkorporing af redoxaktive aminosyrer i protiener
|
AU2005319099B2
(en)
|
2004-02-02 |
2010-09-16 |
Ambrx, Inc. |
Modified human growth hormone
|
AU2005211362B2
(en)
|
2004-02-02 |
2008-03-13 |
Ambrx, Inc. |
Modified human interferon polypeptides and their uses
|
CA2567624A1
(en)
*
|
2004-05-25 |
2005-12-08 |
The Scripps Research Institute |
Site specific incorporation of heavy atom-containing unnatural amino acids into proteins for crystal structure determination
|
CA2568952C
(en)
|
2004-06-18 |
2019-05-21 |
Ambrx, Inc. |
Novel antigen-binding polypeptides and their uses
|
US7718410B2
(en)
|
2004-09-21 |
2010-05-18 |
The Scripps Research Institute |
In vivo incorporation of alkynyl amino acids into proteins in eubacteria
|
EP1794312A4
(de)
*
|
2004-09-22 |
2009-08-12 |
Scripps Research Inst |
Ortsspezifische etikettierung von proteinen für nmr-studien
|
WO2006045116A2
(en)
|
2004-10-20 |
2006-04-27 |
The Scripps Research Institute |
In vivo site-specific incorporation of n-acetyl-galactosamine amino acids in eubacteria
|
EP2380982B1
(de)
|
2004-10-27 |
2014-07-16 |
The Scripps Research Institute |
Orthogonale Translationskomponenten für den In-Vivo-Einbau nichtnatürlicher Aminosäuren
|
NZ555386A
(en)
|
2004-12-22 |
2011-01-28 |
Ambrx Inc |
Formulations of human growth hormone comprising a non-naturally encoded amino acid
|
JP4990792B2
(ja)
|
2004-12-22 |
2012-08-01 |
アンブレツクス・インコーポレイテツド |
アミノアシル−tRNAシンテターゼの組成物およびこの使用
|
EP1836316A4
(de)
|
2004-12-22 |
2009-07-22 |
Ambrx Inc |
Verfahren zur expression und reinigung von rekombinantem menschlichem wachstumshormon
|
ATE529442T1
(de)
|
2005-06-03 |
2011-11-15 |
Ambrx Inc |
Verbesserte humane interferon-moleküle und ihre verwendungen
|
JP2009511053A
(ja)
*
|
2005-10-12 |
2009-03-19 |
ザ スクリップス リサーチ インスティテュート |
ファージ提示型ポリペプチドの選択的翻訳後修飾
|
EP1951890A4
(de)
|
2005-11-16 |
2009-06-24 |
Ambrx Inc |
Verfahren und zusammensetzungen mit nichtnatürlichen aminosäuren
|
AU2006330947B2
(en)
|
2005-12-22 |
2012-04-12 |
Pacific Biosciences Of California, Inc. |
Polymerases for nucleotide analogue incorporation
|
ES2432391T3
(es)
*
|
2006-03-09 |
2013-12-03 |
The Scripps Research Institute |
Sistema para la expresión de componentes de traducción ortogonales en células huésped eubacterianas
|
RU2464315C2
(ru)
|
2006-03-16 |
2012-10-20 |
Зе Скрипс Ресеч Инститьют |
Генетически запрограммированная экспрессия белков, содержащих не встречающуюся в природе аминокислоту фенилселеноцистеин
|
MX2008014776A
(es)
*
|
2006-05-23 |
2008-11-28 |
Scripps Research Inst |
Aminoacidos de cumarina fluorescentes geneticamente codificados.
|
EP2615108B1
(de)
|
2006-09-08 |
2016-10-26 |
Ambrx, Inc. |
Modifiziertes humanes Plasmapolypeptid oder Fc-Gerüste und deren Verwendungen
|
MX2009002526A
(es)
|
2006-09-08 |
2009-04-16 |
Ambrx Inc |
Transcripcion de tarn supresor en celulas de vertebrados.
|
JP5385143B2
(ja)
*
|
2006-09-21 |
2014-01-08 |
ザ スクリプス リサーチ インスティチュート |
真正細菌における選択的に硫酸化された蛋白質の遺伝的にプログラムされた発現
|
KR20090094812A
(ko)
|
2006-10-18 |
2009-09-08 |
더 스크립스 리서치 인스티튜트 |
포유동물 세포에서 비천연 아미노산의 단백질 내로의 유전적 도입
|
ATE554785T1
(de)
|
2007-03-30 |
2012-05-15 |
Ambrx Inc |
Modifizierte fgf-21 polypeptide und ihre verwendung
|
WO2008137471A2
(en)
|
2007-05-02 |
2008-11-13 |
Ambrx, Inc. |
Modified interferon beta polypeptides and their uses
|
RU2010116872A
(ru)
*
|
2007-10-25 |
2011-11-27 |
Зе Скрипс Ресеч Инститьют (Us) |
Генетическое включение 3-аминотирозина в редуктазы
|
EP2220218A4
(de)
*
|
2007-11-02 |
2010-12-08 |
Scripps Research Inst |
Genetisch codierte boronat-aminosäure
|
US9249408B2
(en)
*
|
2007-11-02 |
2016-02-02 |
The Scripps Research Institute |
Directed evolution using proteins comprising unnatural amino acids
|
EP2930182A1
(de)
|
2007-11-20 |
2015-10-14 |
Ambrx, Inc. |
Modifizierte insulinpolypeptide und deren verwendungen
|
US8647840B2
(en)
|
2007-12-11 |
2014-02-11 |
The Scripps Research Institute |
In vivo unnatural amino acid expression in the methylotrophic yeast Pichia pastoris
|
SG188143A1
(en)
|
2008-02-08 |
2013-03-28 |
Ambrx Inc |
Modified leptin polypeptides and their uses
|
EP2249865A4
(de)
*
|
2008-02-08 |
2012-04-04 |
Scripps Research Inst |
Brechung der immunologischen toleranz mit einer genetisch kodierten unnatürlichen aminosäure
|
US20110076718A1
(en)
*
|
2008-02-27 |
2011-03-31 |
The Scripps Research Institute |
In vivo incorporation of an unnatural amino acid comprising a 1,2-aminothiol group
|
EP2942404B1
(de)
|
2008-03-31 |
2016-11-23 |
Pacific Biosciences of California, Inc. |
Erzeugung modifizierter polymerasen für erhöhte genauigkeit bei einzelmolekülsequenzierungen
|
US10138283B2
(en)
|
2008-07-23 |
2018-11-27 |
Ambrx, Inc. |
Modified bovine G-CSF polypeptides and their uses
|
MX2011003196A
(es)
|
2008-09-26 |
2011-04-27 |
Ambrx Inc |
Microorganismos y vacunas dependientes de replicacion de aminoacidos no naturales.
|
CN102232085A
(zh)
|
2008-09-26 |
2011-11-02 |
Ambrx公司 |
修饰的动物促红细胞生成素多肽和其用途
|
US20090197339A1
(en)
*
|
2008-12-10 |
2009-08-06 |
The Scripps Research Institute |
In vivo unnatural amino acid expression in the methylotrophic yeast pichia pastoris
|
WO2010068278A2
(en)
|
2008-12-10 |
2010-06-17 |
The Scripps Research Institute |
Production of carrier-peptide conjugates using chemically reactive unnatural amino acids
|
BR112012015597A2
(pt)
|
2009-12-21 |
2017-01-31 |
Ambrx Inc |
peptídeos de somatotropina suínos modificados e seus usos
|
MX349301B
(es)
|
2009-12-21 |
2017-07-21 |
Ambrx Inc |
Polipéptidos de somatotropina bovina modificados y sus usos.
|
AU2011248625B2
(en)
|
2010-04-26 |
2017-01-05 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-tRNA synthetase
|
AU2011248521B2
(en)
|
2010-04-27 |
2017-03-16 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl tRNA synthetases
|
JP6294074B2
(ja)
|
2010-04-27 |
2018-03-14 |
エータイアー ファーマ, インコーポレイテッド |
イソロイシルtRNA合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
|
WO2011139853A2
(en)
*
|
2010-04-28 |
2011-11-10 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl trna synthetases
|
CA2797393C
(en)
|
2010-04-29 |
2020-03-10 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases
|
CA2797374C
(en)
|
2010-04-29 |
2021-02-16 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of asparaginyl trna synthetases
|
US9068177B2
(en)
|
2010-04-29 |
2015-06-30 |
Atyr Pharma, Inc |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-tRNA synthetases
|
CA2797978C
(en)
|
2010-05-03 |
2019-12-03 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-trna synthetases
|
CN103096925A
(zh)
|
2010-05-03 |
2013-05-08 |
Atyr医药公司 |
与精氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
|
CN103096912A
(zh)
|
2010-05-03 |
2013-05-08 |
Atyr医药公司 |
与苯丙氨酰-α-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
|
WO2011139988A2
(en)
|
2010-05-03 |
2011-11-10 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of seryl-trna synthetases
|
CN102985103A
(zh)
|
2010-05-04 |
2013-03-20 |
Atyr医药公司 |
与p38多-tRNA合成酶复合物相关的治疗、诊断和抗体组合物的创新发现
|
EP2566492B1
(de)
|
2010-05-04 |
2016-10-26 |
aTyr Pharma, Inc. |
Innovative entdeckung therapeutischer zusammensetzungen im zusammenhang mit proteinfragmenten von glutamyl-prolyl-trna-synthetasen
|
JP6396656B2
(ja)
|
2010-05-14 |
2018-09-26 |
エータイアー ファーマ, インコーポレイテッド |
フェニルアラニルβtRNA合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
|
JP6027965B2
(ja)
|
2010-05-17 |
2016-11-16 |
エータイアー ファーマ, インコーポレイテッド |
ロイシルtRNA合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
|
US8962560B2
(en)
|
2010-06-01 |
2015-02-24 |
Atyr Pharma Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Lysyl-tRNA synthetases
|
US20130202576A1
(en)
|
2010-07-12 |
2013-08-08 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases
|
CA2804416C
(en)
|
2010-07-12 |
2020-04-28 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases
|
WO2012009289A2
(en)
|
2010-07-12 |
2012-01-19 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of aspartyl-trna synthetases
|
US8999321B2
(en)
|
2010-07-12 |
2015-04-07 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases
|
HUE045845T2
(hu)
|
2010-08-17 |
2021-12-28 |
Ambrx Inc |
Módosított relaxin polipeptidek és felhasználásuk
|
US9567386B2
(en)
|
2010-08-17 |
2017-02-14 |
Ambrx, Inc. |
Therapeutic uses of modified relaxin polypeptides
|
AU2011293294B2
(en)
|
2010-08-25 |
2016-03-24 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Tyrosyl-tRNA synthetases
|
AR083006A1
(es)
|
2010-09-23 |
2013-01-23 |
Lilly Co Eli |
Formulaciones para el factor estimulante de colonias de granulocitos (g-csf) bovino y variantes de las mismas
|
EP2624857B1
(de)
|
2010-10-06 |
2017-08-02 |
aTyr Pharma, Inc. |
Innovative entdeckung therapeutischer, diagnostischer und antikörperhaltiger zusammensetzungen im zusammenhang mit proteinfragmenten von tryptophanyl-trna-synthetasen
|
US20130078671A1
(en)
*
|
2011-03-25 |
2013-03-28 |
The Texas A&M University System |
Incorporation of two different noncanonical amino acids into a single protein
|
US9714419B2
(en)
|
2011-08-09 |
2017-07-25 |
Atyr Pharma, Inc. |
PEGylated tyrosyl-tRNA synthetase polypeptides
|
US9816084B2
(en)
|
2011-12-06 |
2017-11-14 |
Atyr Pharma, Inc. |
Aspartyl-tRNA synthetases
|
WO2013086228A1
(en)
|
2011-12-06 |
2013-06-13 |
Atyr Pharma, Inc. |
Pegylated aspartyl-trna synthetase polypeptides
|
CN102517241B
(zh)
*
|
2011-12-19 |
2013-06-19 |
中国药科大学 |
一种含有d型氨基酸的双羰基还原酶的突变体的制备方法
|
CN104220461A
(zh)
|
2011-12-29 |
2014-12-17 |
Atyr医药公司 |
天冬氨酰-tRNA合成酶-FC缀合物
|
WO2013171485A1
(en)
*
|
2012-05-18 |
2013-11-21 |
Medical Research Council |
Methods of incorporating an amino acid comprising a bcn group into a polypeptide using an orthogonal codon encoding it and an orthorgonal pylrs synthase.
|
UY35368A
(es)
|
2013-03-08 |
2014-10-31 |
Irm Llc |
Péptidos y composiciones para el tratamiento de daño articular
|
DK3460054T3
(da)
|
2013-03-15 |
2021-01-18 |
Atyr Pharma Inc |
Histidyl-tRNA-syntetase-Fc-konjugater
|
CN104099360A
(zh)
*
|
2013-04-12 |
2014-10-15 |
北京大学 |
非天然氨基酸标记的目的蛋白或肽的制备
|
WO2015009948A1
(en)
|
2013-07-19 |
2015-01-22 |
Regents Of The University Of California |
Milk fat globule epidermal growth factor 8 regulates fatty acid uptake
|
US20150044192A1
(en)
|
2013-08-09 |
2015-02-12 |
President And Fellows Of Harvard College |
Methods for identifying a target site of a cas9 nuclease
|
US9359599B2
(en)
|
2013-08-22 |
2016-06-07 |
President And Fellows Of Harvard College |
Engineered transcription activator-like effector (TALE) domains and uses thereof
|
US9322037B2
(en)
|
2013-09-06 |
2016-04-26 |
President And Fellows Of Harvard College |
Cas9-FokI fusion proteins and uses thereof
|
US9340799B2
(en)
|
2013-09-06 |
2016-05-17 |
President And Fellows Of Harvard College |
MRNA-sensing switchable gRNAs
|
US9737604B2
(en)
|
2013-09-06 |
2017-08-22 |
President And Fellows Of Harvard College |
Use of cationic lipids to deliver CAS9
|
US20150166982A1
(en)
|
2013-12-12 |
2015-06-18 |
President And Fellows Of Harvard College |
Methods for correcting pi3k point mutations
|
WO2016022363A2
(en)
|
2014-07-30 |
2016-02-11 |
President And Fellows Of Harvard College |
Cas9 proteins including ligand-dependent inteins
|
EA036697B1
(ru)
|
2014-10-24 |
2020-12-09 |
Бристол-Майерс Сквибб Компани |
Модифицированные полипептиды fgf-21 и их применение
|
KR20180034588A
(ko)
|
2015-07-30 |
2018-04-04 |
마크로제닉스, 인크. |
Pd-1-결합 분자 및 그것의 사용 방법
|
JP7109784B2
(ja)
|
2015-10-23 |
2022-08-01 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
遺伝子編集のための進化したCas9蛋白質
|
CR20180318A
(es)
|
2015-12-14 |
2018-09-19 |
Macrogenics Inc |
Moléculas biespecíficas que tienen inmunorreactividad con pd-1 y ctla-4, y métodos de uso de las mismas
|
WO2018027078A1
(en)
|
2016-08-03 |
2018-02-08 |
President And Fellows Of Harard College |
Adenosine nucleobase editors and uses thereof
|
US11661590B2
(en)
|
2016-08-09 |
2023-05-30 |
President And Fellows Of Harvard College |
Programmable CAS9-recombinase fusion proteins and uses thereof
|
US11542509B2
(en)
|
2016-08-24 |
2023-01-03 |
President And Fellows Of Harvard College |
Incorporation of unnatural amino acids into proteins using base editing
|
WO2018071868A1
(en)
|
2016-10-14 |
2018-04-19 |
President And Fellows Of Harvard College |
Aav delivery of nucleobase editors
|
EP3538127A1
(de)
|
2016-11-14 |
2019-09-18 |
Novartis AG |
Verfahren und zusammensetzungen zur behandlung von knorpelschäden und arthritis
|
WO2018119359A1
(en)
|
2016-12-23 |
2018-06-28 |
President And Fellows Of Harvard College |
Editing of ccr5 receptor gene to protect against hiv infection
|
CA3052639A1
(en)
|
2017-02-08 |
2018-08-16 |
Bristol-Myers Squibb Company |
Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof
|
WO2018165504A1
(en)
|
2017-03-09 |
2018-09-13 |
President And Fellows Of Harvard College |
Suppression of pain by gene editing
|
KR20190127797A
(ko)
|
2017-03-10 |
2019-11-13 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
시토신에서 구아닌으로의 염기 편집제
|
CA3057192A1
(en)
|
2017-03-23 |
2018-09-27 |
President And Fellows Of Harvard College |
Nucleobase editors comprising nucleic acid programmable dna binding proteins
|
JP2020517638A
(ja)
|
2017-04-20 |
2020-06-18 |
エータイアー ファーマ, インコーポレイテッド |
肺の炎症を治療するための組成物および方法
|
US11560566B2
(en)
|
2017-05-12 |
2023-01-24 |
President And Fellows Of Harvard College |
Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation
|
US11732274B2
(en)
|
2017-07-28 |
2023-08-22 |
President And Fellows Of Harvard College |
Methods and compositions for evolving base editors using phage-assisted continuous evolution (PACE)
|
US11319532B2
(en)
|
2017-08-30 |
2022-05-03 |
President And Fellows Of Harvard College |
High efficiency base editors comprising Gam
|
CA3082251A1
(en)
|
2017-10-16 |
2019-04-25 |
The Broad Institute, Inc. |
Uses of adenosine base editors
|
LU100734B1
(en)
|
2018-03-15 |
2019-10-01 |
Univ Hamburg |
Synthetic transfer RNA with extended anticodon loop
|
AU2019233673A1
(en)
|
2018-03-15 |
2020-11-12 |
Arcturus Therapeutics, Inc. |
Synthetic transfer RNA with extended anticodon loop
|
CN112236622A
(zh)
|
2018-03-27 |
2021-01-15 |
艾斯彼控股,耐催德点火器有限公司的商定名称 |
用于灶具的热表面点火器
|
BR112020022288A2
(pt)
|
2018-05-01 |
2021-02-23 |
Ambrx, Inc. |
método para otimizar a expressão de anticorpos
|
FI3849614T3
(fi)
|
2018-09-11 |
2024-02-08 |
Ambrx Inc |
Interleukiini-2-polypeptidikonjugaatteja ja niiden käyttöjä
|
JP2022512746A
(ja)
|
2018-10-19 |
2022-02-07 |
アンブルックス,インコーポレイテッド |
インターロイキン-10ポリペプチド複合体、その二量体、およびそれらの使用
|
CN111718920B
(zh)
*
|
2019-03-19 |
2021-05-07 |
宁波鲲鹏生物科技有限公司 |
在蛋白中高效引入赖氨酸衍生物的氨酰基-tRNA合成酶
|
MX2021011426A
(es)
|
2019-03-19 |
2022-03-11 |
Broad Inst Inc |
Metodos y composiciones para editar secuencias de nucleótidos.
|
LU101182B1
(en)
*
|
2019-04-11 |
2020-10-12 |
Univ Hamburg |
Synthetic transfer RNA with extended anticodon loop
|
US20220162612A1
(en)
|
2019-04-11 |
2022-05-26 |
Arcturus Therapeutics, Inc. |
Synthetic transfer rna with extended anticodon loop
|
CN110172467B
(zh)
*
|
2019-05-24 |
2021-03-16 |
浙江大学 |
一种利用嵌合设计方法构建正交的氨酰-tRNA合成酶/tRNA体系
|
AU2021233909A1
(en)
|
2020-03-11 |
2022-09-29 |
Ambrx, Inc. |
Interleukin-2 polypeptide conjugates and methods of use thereof
|
IL297761A
(en)
|
2020-05-08 |
2022-12-01 |
Broad Inst Inc |
Methods and compositions for simultaneously editing two helices of a designated double-helix nucleotide sequence
|
KR20240040134A
(ko)
|
2021-07-09 |
2024-03-27 |
브라이트 피크 테라퓨틱스 아게 |
항체 접합체 및 이의 제조
|
WO2023281485A1
(en)
|
2021-07-09 |
2023-01-12 |
Bright Peak Therapeutics Ag |
Modified il-2 polypeptides for treatment of inflammatory and autoimmune diseases
|
WO2023281482A1
(en)
|
2021-07-09 |
2023-01-12 |
Bright Peak Therapeutics Ag |
Cd20-targeted il-2 and its uses
|
US20230250181A1
(en)
|
2021-07-09 |
2023-08-10 |
Bright Peak Therapeutics Ag |
Modified checkpoint inhibitors and uses thereof
|
WO2023281480A1
(en)
|
2021-07-09 |
2023-01-12 |
Bright Peak Therapeutics Ag |
Conjugates of checkpoint inhibitors with il-2, and uses thereof
|
WO2023069816A2
(en)
|
2021-09-20 |
2023-04-27 |
The Broad Institute, Inc. |
Compositions and methods for multiplex decoding of quadruplet codons
|
WO2023161857A1
(en)
|
2022-02-23 |
2023-08-31 |
Bright Peak Therapeutics Ag |
Bifunctional cytokine compositions
|
US20230355795A1
(en)
|
2022-02-23 |
2023-11-09 |
Bright Peak Therapeutics Ag |
Immune antigen specific il-18 immunocytokines and uses thereof
|
CN114908066B
(zh)
*
|
2022-05-17 |
2024-01-23 |
杭州嵌化合生医药科技有限公司 |
一种正交翻译系统及其在再分配密码子恢复ptc疾病中功能蛋白表达方面的应用
|
CN115975978B
(zh)
*
|
2023-02-01 |
2023-08-01 |
珠海宝锐生物科技有限公司 |
Bst DNA聚合酶大片段突变体及其应用
|